<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376061/" ref="ordinalpos=1174&amp;ncbi_uid=4124358&amp;link_uid=PMC3376061" image-link="/pmc/articles/PMC3376061/figure/F1/" class="imagepopup">Figure. From: The CD95 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody"><b>Figure 1.</b> Role of the Orai1-driven Ca2+ entry in T lymphocytes challenged with the different forms of CD95L. When exposed to the two forms of CD95L, cleaved and membrane-bound, activated T lymphocytes, target cells (infected or transformed cells) or bystander cells undergo an Orai1-driven Ca2+ entry that modulates differently the CD95-mediated signaling pathway. The Ca2+ traces obtained with cells exposed to cleaved-CD95L (1) or membrane-bound CD95L (2) are depicted. MHC: Major Histocompatibility Complex.</div></div>